ANIP - ANI Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

ANIP is currently covered by 2 analysts with an average price target of $111. This is a potential upside of $38.76 (53.65%) from yesterday's end of day stock price of $72.24.

ANI Pharmaceuticals's activity chart (see below) currently has 137 price targets and 94 ratings on display. The stock rating distribution of ANIP is 66.67% BUY and 33.33% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 78.11% with an average time for these price targets to be met of 384.31 days.

Highest price target for ANIP is $124, Lowest price target is $90, average price target is $111.

Most recent stock forecast was given by VAMIL DIVAN from GUGGENHEIM on 10-Aug-2026. First documented stock forecast 15-Dec-2014.

Currently out of the existing stock ratings of ANIP, 4 are a BUY (66.67%), 2 are a HOLD (33.33%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 28-Feb-2023

$119

$46.71 (64.61%)

$124

2 months 11 days ago
(10-Aug-2026)

7/12 (58.33%)

$43.24 (57.07%)

320

Hold Since 17-Jul-2026

$90

$17.71 (24.50%)

$91

2 months 11 days ago
(10-Aug-2026)

0/2 (0%)

$14.24 (18.80%)

Buy Since 11-Dec-2024

$103

$30.71 (42.48%)

$100

1 years 6 days ago
(15-Oct-2025)

2/4 (50%)

$12.9 (14.32%)

202

Hold Since 22-Oct-2024

$90

$17.71 (24.50%)

$77

1 years 12 days ago
(09-Oct-2025)

13/13 (100%)

$-0.78 (-0.86%)

298

Buy Since 12-Mar-2025

$115

$30.5 (36.09%)

$85

1 years 27 days ago
(24-Sep-2025)

1/2 (50%)

$20.01 (21.07%)

153

Show more analysts

Please expand the browser size to see the chart

What is ANIP (ANI Pharmaceuticals) average time for price targets to be met?

On average it took 384 days for the stock forecasts to be reached, with an average price target met ratio of 78.11%.

Which analyst most recently updated their price target on ANIP (ANI Pharmaceuticals)?

Vamil Divan

Which analyst has the most public recommendations on ANIP (ANI Pharmaceuticals)?

Vamil Divan works at GUGGENHEIM and has 18 price targets and 12 ratings on ANIP

Which analyst is the currently most bullish on ANIP (ANI Pharmaceuticals)?

Brandon Folkes with the highest potential upside of $48.71

Which analyst is the currently most reserved on ANIP (ANI Pharmaceuticals)?

Elliot Wilbur with the lowest potential downside of -$23.29
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?